Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors.

Drug Design, Development and Therapy
Xuan HuangDelong Liu

Abstract

Chronic myeloid leukemia (CML) is characterized by a Philadelphia chromosome which contains an oncogene, bcr-abl. This oncogene encodes a tyrosine kinase which is constitutively activated. Imatinib, a tyrosine kinase inhibitor (TKI), has been widely used in the treatment of CML. Dasatinib and nilotinib were recently approved for the treatment of CML. Other TKIs, such as bosutinib, erlotinib, and sunitinib, are under study for the treatment of CML as well as other hematologic and solid malignancies. Skin rash has been reported as one of the most common side effects of the TKIs. Here we present a case of severe skin rash together with unusual symptoms of high fever and diarrhea induced by imatinib in a CML patient. The dermatologic toxicities from a variety of tyrosine kinase inhibitors are reviewed and general principles of management are also discussed.

References

Jul 15, 1999·The New England Journal of Medicine·S FaderlH M Kantarjian
Nov 5, 2002·Blood·Simon A J RuleLucy C Crossman
Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienUNKNOWN IRIS Investigators
Jun 1, 2004·The Oncologist·François Guilhot
Jul 6, 2004·Clinical Biochemistry·Srinivasan Madhusudan, Trivadi S Ganesan
Jul 5, 2005·The Lancet Oncology·Caroline RobertThierry Le Chevalier
Jul 14, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Segaert, E Van Cutsem
Jan 31, 2006·Journal of the American Academy of Dermatology·Susan Journagan, Joseph Obadiah
Jun 16, 2006·The New England Journal of Medicine·Hagop KantarjianOliver G Ottmann
Jun 16, 2006·The New England Journal of Medicine·Sarit AssoulineCarlo Gambacorti-Passerini
Oct 3, 2006·Journal of the American Academy of Dermatology·Anna Liza C AgeroAllan C Halpern
Oct 7, 2006·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Sarah M GressettFred Hardwicke
Dec 8, 2006·The New England Journal of Medicine·Brian J DrukerUNKNOWN IRIS Investigators
Dec 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kun-Ying TsaiJohn W C Chang
Jul 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bret WackerPablo J Cagnoni
Aug 3, 2007·The Journal of Clinical Investigation·Peter C Nowell
Aug 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Quincy S C ChuEric K Rowinsky
Sep 1, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S BoeckV Heinemann

❮ Previous
Next ❯

Citations

Nov 27, 2010·Journal of Hematology & Oncology·Guoqing WeiDelong Liu
Jan 17, 2015·Journal of the American Academy of Dermatology·James B MacdonaldAleksandar Sekulic

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Giuseppe SaglioENESTnd Investigators
The New England Journal of Medicine
M Brouard, J H Saurat
The New England Journal of Medicine
Sarit AssoulineCarlo Gambacorti-Passerini
© 2022 Meta ULC. All rights reserved